RT Journal Article
SR Electronic
T1 Tislelizumab plus chemotherapy for patients with <em>EGFR</em>-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006887
DO 10.1136/jitc-2023-006887
VO 11
IS 8
A1 Zhong, Hua
A1 Zhang, Xueyan
A1 Tian, Panwen
A1 Chu, Tianqing
A1 Guo, Qisen
A1 Yu, Xinmin
A1 Yu, Zhuang
A1 Li, Yalun
A1 Chen, Lijuan
A1 Liu, Jie
A1 Zhang, Yan
A1 Guan, Yan
A1 Shi, Xun
A1 Wang, Jing
A1 Zhao, Yanqiu
A1 Han, Baohui
YR 2023
UL http://jitc.bmj.com/content/11/8/e006887.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.